A Phase 3 Study of AGA111 in Patients With Degenerative Disc Disease Undergoing Lumbar Interbody Fusion

AGA111 is locally administered in an ABC carrier at the intervertebral space during the lumbar interbody fusion.

Placebo is locally administered in an ABC carrier at the intervertebral space during the lumbar interbody fusion.